Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Fascioliasis Market

Published Date : Mar 2023

The global fascioliasis market is estimated to be valued at US$ 361.3 million in 2023 and is expected to exhibit a CAGR of 4.52% during the forecast period (2023-2030). ... View more

Coherent Market Insights U S Urea Cycle Disorders Treatment Market

Published Date : Mar 2023

U.S. Urea Cycle Disorders Treatment market is estimated to be valued at US$ 510.0 million in 2023 and is expected to exhibit a CAGR of 3.56% during the forecast period (2023-2030). In... View more

Coherent Market Insights Over The Counter Otc Analgesics Market

Published Date : Mar 2023

The global over the counter (OTC) analgesics market was valued at US$ 28.55 Bn in 2022 and is forecast to reach a value of US$ 39.74 Bn by 2030 at a CAGR of 4.84%&nb... View more

Coherent Market Insights Calcium Pantothenate Market

Published Date : Feb 2023

Calcium Pantothenate is a white salt C18H32CaN2O10 made synthetically and used as a source of pantothenic acid. It is a dietary supplement. It is utilized to treat pantothenic acid deficiency (Vitamin B5). It is also used to treat hair loss brought on by a lack of vit... View more

Coherent Market Insights Digestive Drugs Market

Published Date : Feb 2023

Any medicines that are taken and has effect on the digestive system are referred to as digestive drugs. These medicines can be over-the-counter (OTC) and prescription drugs. Medications that are commonly used for digestive conditions such as inflammatory bowel disease... View more

Coherent Market Insights Alpha Emitter Market

Published Date : Jul 2023

Global alpha emitter market is estimated to be valued at US$ 1,331.0 million in 2023 and is expected to exhibit a CAGR of 10.3 % during the forecast period (2023-2030). ... View more

Coherent Market Insights Dna Sequencing Market

Published Date : Feb 2023

DNA sequencing refers to a common laboratory technique that determines the exact sequence of nucleotides or bases in a DNA molecule. Sequences of bases (often identified by the first letters of their chemical names, A, T, C, and G) encode biological information that c... View more

Coherent Market Insights Poultry Vaccine Market

Published Date : Feb 2023

The global poultry vaccine market was valued at US$ 1,766.8 Mn in 2022 and is forecast to reach a value of US$ 3,240.2 Mn by 2030 at a CAGR of 7.9% between ... View more

Coherent Market Insights Ornithine Transcarbamylase Otc Deficiency Treatment Market

Published Date : Jan 2023

Global Ornithine Transcarbamylase (OTC) deficiency treatment market is estimated to be valued at US$ 810.4 million in 2023 and is expected to exhibit a CAGR of 4.25% during the forecast period ... View more

Coherent Market Insights Genetic Chronic Obstructive Pulmonary Disease Copd Market

Published Date : Jan 2023

The genetic disorder known as Alpha-1 Antitrypsin Deficiency (Alpha-1) is transmitted from parents to their offspring through their DNA. Genes are the instructions or coding that human body's cells follow to give us characteristics like blue eyes, black hair, etc. We ... View more

Coherent Market Insights Anesthesia Gases Market

Published Date : Jan 2023

The global anesthesia gases market was valued at US$ 1,765.0 Mn in 2021 and is forecast to reach a value of US$ 2,266.9 Mn by 2028 at a CAGR of 3.6% between ... View more

Coherent Market Insights Dermatological Therapeutic Market

Published Date : Jan 2023

The global dermatological therapeutic market was valued at US$ 37,198.7 Mn in 2021 and is forecast to reach a value of US$ 63,917.4 Mn by 2028 at a CAGR of 8.0% ... View more

Coherent Market Insights Tamiflu Oseltamivir Phosphate Market

Published Date : Jan 2023

Tamiflu (oseltamivir phosphate) is an anti-viral drug which is indicated for the treatment of acute, uncomplicated influenza A and B as well as swine flu in patients two weeks of age and older and whose flu symptoms have not lasted for more than two days. The product ... View more

Coherent Market Insights Anticoagulant Market

Published Date : Jan 2023

The global anticoagulant market was valued at US$ 30,773.2 Mn in 2021 and is forecast to reach a value of US$ 57,337.5 Mn by 2028 at a CAGR of 9.4% between ... View more

Coherent Market Insights Heparin Calcium Market

Published Date : Jan 2023

Heparin calcium is an anticoagulant which is oindicated for the prevention and treatment of thrombotic events such as pulmonary embolism, deep vein thrombosis, and others. Unfractionated and low molecular weight heparin are the two form of heparin calcium. Unfractiona... View more

Coherent Market Insights Veterinary Excipients Market

Published Date : Jan 2023

The substance used in medicine formulation alongside the active ingredient of a medication, included for the purpose of long-term stabilization, bulking up solid formulations that contain potent active ingredients in small amounts or to confer a therapeutic enhancemen... View more

Coherent Market Insights Betamethasone Acetate Market

Published Date : Jan 2023

Betamethasone acetate is a white to off-white, odorless powder that resolidifies at approximately 165°C, decomposes and remelts at approximately 200°C to 220°C. It is practically insoluble in water, freely soluble in acetone, and soluble in alcohol and chl... View more

Coherent Market Insights Diphtheria Vaccine Market

Published Date : Jan 2023

The bacteria corynebacterium diphtheriae produce a toxin which causes diphtheria. Diphtheria bacteria are typically transmitted from person to person through respiratory droplets such as those produced by coughing or sneezing. The bacteria produce a toxin that destroy... View more

Coherent Market Insights Postmenopausal Osteoporosis Market

Published Date : Jan 2023

Postmenopausal osteoporosis is caused due to estrogen deficiency, which is the most common type of osteoporosis. Estrogen deficiency results in an increase in bone turnover owing to effects on all types of bone cells. The imbalance in bone formation and resorption has... View more

Coherent Market Insights Pancreatic Cancer Therapeutics And Diagnostic Market

Published Date : Jan 2023

The global pancreatic cancer therapeutics and diagnostic market was valued at US$ 3,689.6 Mn in 2021 and is forecast to reach a value of US$ 6,039.3 Mn by 2028 at a CAGR of 7... View more

© 2023 Coherent Market Insights Pvt Ltd. All Rights Reserved.